Skip to main content
. 2021 Jun 3;31(12):1871–1883. doi: 10.1007/s00787-021-01804-8

Table 2.

Percentages of clinical responders per group and results of chi-square analyses

PRT total TAU Chi-square analyses results
% Endpoint % Follow-up % Endpoint % Follow-up Endpoint Follow-up
PRT PRT + robot PRT PRT  + robot X2(df) p X2(df) p
Outcome
 Comparison
SRS parents
 2-group 20.8 30.6 18.2 20.0 0.06 (1) 0.797 0.80 (1) 0.371
 3-group 13.0 28.0 12.0 50.0 10.72 (2) 0.419 90.66 (2) 0.008**
SRS teachers
 2-group 27.3 25.6 18.2 21.7 0.66 (1) 0.417 0.12 (1) 0.729
 3-group 13.0 42.9 16.7 36.8 50.75 (2) 0.050 20.47 (2) 0.291
CGI-I
 2-group 55.1 59.2 36.4 45.5 2.13 (1) 0.144 10.16 (1) 0.282
 3-group 44.0 66.7 48.0 70.8 40.65 (2) 0.098 30.74 (2) 0.155
ADOS-2
 2-group 38.6 22.2 1.54 (1) 0.215
 3-group 13.6 63.6 130.81 (2) 0.009**
OBVL
 2-group 64.6 63.3 66.7 57.9 0.23 (1) 0.867 0.17 (1) 0.683
 3-group 73.9 56.0 64.0 62.5 10.72 (2) 0.423 0.18 (2) 0.914

ADOS Autism Diagnostic Observation Schedule second edition, CGI-I Clinical Global Impression- Improvement scale, df degrees of freedom, OBVL Dutch Opvoedingsbelasting vragenlijst, pp value (two-tailed); PRT = group of participants who received Pivotal Response Treatment, PRT + robot group of participants who received robot-assisted Pivotal Response Treatment, PRT total total group of participants that received PRT, SRS Social Responsiveness Scale, TAU group of participants who received treatment-as-usual, X2 test statistic resulting from Chi squared analyses, 2-group comparison between PRT total and TAU, 3-group comparison between PRT, PRT + robot and TAU

*p < .05, **p < .01